Sort
39,280 grants matching “leukemia”
Epigenetic Control of Hematopoietic Gene Expression
$332,044Gerd A Blobel · Children'S Hosp Of Philadelphia · R37 · FY2013 · DK
Targeting Endoplasmic Reticulum Stress Sensor IRE1 to Enhance Chemotherapy Sensitivity in MYC-driven breast cancer
$332,039Xi Chen · Baylor College Of Medicine · P50 · FY2023 · CA
Role of Gab2 in Mast Cell Function and Ontogeny
$332,010Haihua Gu · Beth Israel Deaconess Medical Center · R01 · FY2006 · AI
Genomics of AML: Contribution of Cytokine Signaling Pathways to Leukemogenesis
$332,007Michael H Tomasson · Washington University · P01 · FY2012 · CA
The role of PHF6 in T-cell acute lymphoblastic leukemia
$332,000Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2015 · CA
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL
$332,000Fatih M Uckun · Children'S Hospital Of Los Angeles · R01 · FY2012 · CA
The role of ETV6 in T-cell acute lymphoblastic leukemia
$332,000Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2015 · CA
Mechanism of action of Prdm16 in hematopoietic stem cells
$332,000Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2017 · CA
Targeting non-classical oncogenes as therapy for T-ALL
$332,000Thomas G. Diacovo · Columbia University Health Sciences · R01 · FY2015 · CA
Pre-B cell receptor signaling in acute lymphoblastic leukemia
$332,000Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2009 · CA
Deregulation of MSI RNA-binding proteins promotes intestinal tumorigenesis
$332,000Christopher Joachim Lengner · University Of Pennsylvania · R01 · FY2012 · CA
The Role of ATM in Suppression of Lymphomas
$332,000Shan Zha · Columbia University Health Sciences · R01 · FY2012 · CA
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
$332,000Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2010 · CA
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
$332,000Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2012 · CA
Novel Targeted Therapy for AML
$332,000Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Targeting non-classical oncogenes as therapy for T-ALL
$332,000Thomas G. Diacovo · Columbia University Health Sciences · R01 · FY2016 · CA
Mechanism of action of Prdm16 in hematopoietic stem cells
$332,000Hans-Willem E Snoeck · Columbia University Health Sciences · R01 · FY2015 · CA
Targeted Therapy for AML Stem Cells
$332,000Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
The role of ETV6 in T-cell acute lymphoblastic leukemia
$332,000Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2013 · CA
Role of autophagy in normal and transformed hematopoietic stem cells
$332,000Emmanuelle Passegue · Columbia University Health Sciences · R01 · FY2017 · CA
The role of ETV6 in T-cell acute lymphoblastic leukemia
$332,000Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2016 · CA
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL
$332,000Fatih M Uckun · Children'S Hospital Of Los Angeles · R01 · FY2011 · CA
Targeted Therapy for AML Stem Cells
$332,000Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
$332,000Markus Mãschen · Children'S Hospital Of Los Angeles · R01 · FY2009 · CA
Regulation of hematopoietic stem cell and progenitor cell proliferation by Runx1
$332,000Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2015 · CA